Molecular Precision Mental Health

Molecular Precision Mental Health

Prof. Dr. F. Markus Leweke, MD MA FRANZCP
Professor of Psychiatry and Chair in Youth Depression Studies
The University of Sydney

Stacks Image 267



Scientific interests

Trajectories for diagnosis and course of psychiatric disorders
The endocannabinoid system and the lipidome in psychiatric disorders
New psychopharmacological strategies for psychiatric disorders
Integrated and enhanced clinical models of care
Publications
Academic Education and Medical License
1984 to 1991
Study of Medicine, University of Cologne, Cologne (Germany) and
University of New South Wales, Sydney (Australia)
1987 to 1992
MD-student, Dept. of Neurophysiology (Supervisor: Prof. Dr. Uwe Heinemann),
University of Cologne, Cologne (Germany)
1991
Medical State Examination and License as Medical Doctor, Cologne (Germany)
1993
Full License as Medical Doctor, Cologne (Germany)
2013 to 2016
Master program "Healthcare Business Management and Health Economics",
Fresenius University of Applied Sciences, Cologne (Germany)
2016
Master of Arts in Healthcare Business Management and Health Economics
2018
Limited Registration as Psychiatric Specialist, New South Wales (Australia)
2019
Full Registration as Psychiatric Specialist, New South Wales (Australia)
Doctoral degree (Doctor medicinae|M.D.)
1993
Doctor of Medicine, Medical Faculty, University of Cologne, Cologne (Germany)
"Effects of pentylenetrazole and baclofen in rat hippocampus in vitro."
Habilitation (Ph.D. equivalent)
2004
Lecturer and venia legendi (permission for lecturing) in "Psychiatry and Psychotherapy",
Medical Faculty, University of Cologne, Cologne (Germany)
"Endogenous and exogenous cannabinoids in schizophrenia".
Honors
1989
Scholarship from DAAD (German Academic Exchange Service) to study in Australia
1993
Doctorate Award Epilepsy 1993 of the Society for Epilepsy-Research Bethel, Germany
2006
Poster Price, 13th Biennial Winter Workshop on Schizophrenia Research, Davos, Switzerland (Official meeting of the Schizophrenia International Research Society)
2015
DGPPN (German Association for Psychiatry, Psychotherapy and Psychosomatics) Price for Pharmacological Research
Board certificates and training authorizations
1996
Specialist in Psychiatry (Medical Board Lower-Saxonia, Germany)
1999
Specialty Psychotherapy (Medical Board North Rhine, Germany)
2000
Specialist in Neurology (Medical Board North Rhine, Germany)
2003
Specialist in Psychiatry and Psychotherapy (Medical Board North Rhine, Germany)
2009 to 2017
Full training authorisation for Psychiatry and Psychotherapy
(Medical Board North Baden, Germany)
2019
Fellow of the Royal Australian and New Zealand College of Psychiatrists (FRANZCP), Australia
2019
Royal Australian and New Zealand College of Psychiatrists (RANZCP)
accredited supervisor (Australia)
Professional activity
1991 to 1992
Resident, Institute of Neurophysiology, University of Cologne (Germany)
(Prof. Dr. Uwe Heinemann)
1992 to 1993
Resident, Dept. of Neurology, Alfried-Krupp-Hospital, Essen (Germany)
(Directors: Prof. Dr. Johannes Noth and Prof. Dr. Peter Berlit)
1993
Post doc, Institute of Neurophysiology, University of Cologne (Germany)
(Prof. Dr. Uwe Heinemann)
1993 to 1996
Registrar in Psychiatry and Psychotherapy, Dept. of Clinical Psychiatry and Psychotherapy, Medizinische Hochschule Hannover (Germany)
(Director: Prof. Dr. Dr. Hinderk M. Emrich)
1996 to 1997
Registrar in Neurology, Dept. of Epileptology, University of Bonn (Germany)
(Director: Prof. Dr. Christian E. Elger, FRCP)

1997 to 1999

Senior Psychiatrist and Deputy Head, Dept of General Psychiatry – Addiction Medicine, LVR-Kliniken Duesseldorf, Germany (Head: Dr. Wilhelm Burtscheidt),
Dept. of Psychiatry and Psychotherapy, Heinrich-Heine-University Duesseldorf (Germany)
(Director: Prof. Dr. Wolfgang Gaebel)
1998
Research visit at the Neurosciences Institute, San Diego, California (USA)
(Prof. Daniele Piomelli, PhD MD (h.c.))
1999 to 2008
Senior Psychiatrist and Lecturer, Dept. of Psychiatry and Psychotherapy,
University of Cologne, Cologne (Germany)
(Director: Prof. Dr. Joachim Klosterkötter),
Head Research Group Experimental and Clinical Neuropsychopharmacology
2008 to 2009
Deputy Director, ibid.
2009 to 2017
W3 Full Professor of Psychiatry and Psychotherapy, Deputy Chair,
Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg (Germany)

Associate Medical Director, Dept. of Psychiatry and Psychotherapy,
Central Institute of Mental Health, Mannheim (Germany)
(Director: Prof. Dr. A. Meyer-Lindenberg, MD MSci MBA),

Head Center of Excellence of Research in Psychiatry and Psychotherapy
Leader, Research Group 'Translational Research in Psychiatry' (TRiP)
since 2017
Professor and Leader, Research Group 'Translational Research in Psychiatry' (TRiP),
Central Institute of Mental Health, Mannheim, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg (Germany)
since 2017
Professor of Psychiatry and Chair in Youth Depression Studies,
Brain and Mind Centre, Translational Research Collective
Faculty of Medicine and Health, The University of Sydney, Sydney (Australia)
since 2018
Consultant Psychiatrist, Royal Prince Alfred Hospital/CCMH, Sydney Local Health District,
NSW Health, Sydney (Australia)
since 2009
since 2021
since 2021
Founder and Managing Director, curantis UG (ltd.), Bruehl (Germany)
Founder and Chief Medical Officer, Endosane Pharmaceuticals GmbH, Berlin (Germany)
Founder and Managing Director, UBsane Diagnostics UG, Bruehl (Germany)